Related Experiment Video
Updated: Jun 26, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Vanadium compounds as therapeutic agents: some chemical and biochemical studies
H Faneca1, V A Figueiredo, Isabel Tomaz
1Departamento de Bioquímica e Centro de Neurociências e Biologia Celular, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, Apartado 3126, Coimbra, Portugal.
Journal of Inorganic Biochemistry
|December 27, 2008
Summary
This study investigates vanadium(V) complexes, revealing their stability in physiological conditions and potential for antitumor activity. The vanadium(V)-MHCPE system exhibits selective toxicity towards cancer cells, suggesting therapeutic promise.
Area of Science:
- Inorganic Chemistry
- Bioinorganic Chemistry
- Medicinal Chemistry
Background:
- Vanadium(V) complexes are explored for biological applications.
- Understanding the speciation and stability of vanadium(V) complexes in aqueous solutions is crucial for their development.
- Previous studies reported speciation for V(V)-dmpp and V(V)-salDPA systems.
Purpose of the Study:
- To investigate the speciation and behavior of the vanadium(V)-MHCPE complex in aqueous solutions.
- To assess the stability of vanadium(V) complexes under physiological conditions.
- To evaluate the cytotoxic activity and potential antitumor effects of these vanadium(V) complexes.
Main Methods:
- Solution behavior studied using pH-potentiometry and (51)V NMR spectroscopy.
- Speciation analysis at physiological pH (ca. 7).
- Cytotoxicity screening in HeLa tumor cells and 3T3-L1 fibroblasts using IC(50) values.
Main Results:
- The vanadium(V)-MHCPE system forms species like (V(V)O(2))L(2) and (V(V)O(2))LH(-1) at pH 7.
- All studied vanadium(V) species demonstrate stability in various aqueous media, including cell culture environments.
- Vanadium(V)-MHCPE species exhibit concentration- and time-dependent cytotoxicity, with higher efficacy against HeLa tumor cells.
Conclusions:
- Vanadium(V) complexes, particularly V(V)-MHCPE, are stable under physiological conditions.
- The V(V)-MHCPE system shows selective toxicity towards tumor cells over normal cells.
- These findings suggest potential antitumor activity for the V(V)-MHCPE complex.
Related Concept Videos
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:17Antidotes
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...